Events

EP PerMed Symposium: Ethical, legal and social aspects of personalised medicine
SEP
Thu
26
09:00 - 14:00

This was 1 year ago

Location

Hybrid

Tuscany Region EU Delegation
Rond Point Schuman 14
1040 Brussels
Programmes
Health

The European Partnership for Personalised Medicine (EP PerMed) organises a Symposium on Ethical, Legal and Social Aspects (ELSA) of Personalised Medicine.

The symposium aims to address the main ethical challenges in personalised medicine research in order to raise awareness and train researchers by addressing ELSA issues in personalised medicine from a macro approach (ethics of new technologies) to a specific approach (ethics, legal issues, privacy issues and artificial intelligence (AI) in personalised medicine).

More information, the detailed agenda and registration (on-site or virtual) on the EP PerMed website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of ScreenME - Enhancing excellence in screen media entrepreneurship

ScreenME - Enhancing excellence in screen media entrepreneurship

The Horizon2020 twinning project ScreenME has as its objective to enhance excellence in screen media entrepreneurship at Tallinn University (TLU). To do so, ScreenME has established a network of universities across Europe that aim to improve research into and teaching of entrepreneurship for the screen media industry. ScreenME will develop a teaching course and will kick off research initiatives and projects on entrepreneurial activities in media organisations. The research group on ‘Studies in Media, Innovation and Technology (SMIT)’ of the Vrije Universiteit Brussel (VUB) is partner in the network and is involved in two cross-cutting activities of the project: support for early stage researchers and developing stakeholder involvement.